We show that miR-361-3p inhibition induces apoptosis and inhibition of proliferation across drug-resistant and -responsive BC cell lines in vitro, in vivo and ex vivo through p53-mediated G1 cell cycle arrest and in part through FANCA modulation. This evidence concerns the gene TP53 and breast cancer.